Oracle Introduces Oracle® Health Sciences Central Coding 3.0

New Release Features Advanced Workflow and Expanded Automation that Helps to Boost Productivity for Clinical Trial Teams
Redwood Shores, Calif. - March 2, 2011

News Facts
Oracle today announced the availability of Oracle® Health Sciences Central Coding Release 3.0. The third generation of the Web-based clinical trial data coding and dictionary management application includes expanded query management and automated workflows that help clinical trial sponsors and contract research organizations (CROs) improve the efficiency and consistency of the coding process.
Oracle Health Sciences Central Coding Release 3.0 features enhanced integration with Oracle Health Sciences InForm Global Trial Management Global Trial Management system, which promotes greater productivity via improved query management and workflow.
This release enables users to create and manage Oracle Health Sciences InForm Global Trial Management queries directly in Oracle Health Sciences Central Coding Release 3.0, streamlining the coding process with one point of entry to apply and manage coding updates to all Oracle Health Sciences InForm Global Trial Management-managed trials in process.
A flexible, multilingual application that automates coding and minimizes the manual effort required to code verbatim terms, Oracle Health Sciences Central Coding Release 3.0 is the first coding solution to be certified by the Uppsala Monitoring Centre, the World Health Organization collaborative center for international drug monitoring.
The release features a new user interface and simplified status information. Customizable flags and status options enable users to tailor and optimize their workflow.
Auto-query, propagate and auto-close tools significantly enhance productivity by reducing the manual effort required to raise and resolve queries.
Oracle Health Sciences Central Coding Release 3.0 benefitted from substantial user community participation and feedback, helping to deliver a richer and more broadly tested solution.

Supporting Quote
"Consistent coding is fundamental to normalizing data for analysis and regulatory submission, but it's no easy task in today's complex, global research environment," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "Integration is critical to achieving the necessary workflows to efficiently code across multiple trials in multiple languages. Oracle Health Sciences Central Coding Release 3.0 provides clinical trial sponsors a more effective means to review, resolve and approve terms across trials and regions."

Supporting Resources
Oracle in Health SciencesFollow Oracle Health Sciences on Twitter
Join the Oracle Health Sciences Community on Facebook

About Oracle
Oracle (NASDAQ: ORCL) is the world's most complete, open, and integrated business software and hardware systems company.  For more information about Oracle, visit oracle.com

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.